Top Markets
Coin of the day
Cambridge Nutritional Sciences plc Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc

CNSL
Rank in Stocks #40938
Established in 1987 and headquartered in London, UK, Cambridge Nutritional... Established in 1987 and headquartered in London, UK, Cambridge Nutritional Sciences plc (formerly Omega Diagnostics Group PLC until its name change in September 2023) is a specialist in the development, manufacturing, and supply of medical diagnostic products. The company primarily operates within the food sensitivity testing market, creating and producing "Foodprint" branded kits designed to detect immune reactions to food. Beyond manufacturing, it provides clinical analysis services directly to the public, clinics, and healthcare professionals, and also offers the "Food Detective" consumer food test. Its diverse client base includes government entities, private hospitals, reference laboratories, nutritionists, naturopaths, and other medical practitioners. Cambridge Nutritional Sciences plc boasts a global presence, serving markets across the United Kingdom, continental Europe, North, South, and Central America, India, various other Asian countries and the Far East, Africa, and the Middle East.
Share Price
$0.02517298
Market Cap
$59.90K
Change (1 day)
-2.63%
Change (1 year)
-46.84%
Country
GB
Trade Cambridge Nutritional Sciences plc (CNSL)

Category

Earnings for Cambridge Nutritional Sciences plc (CNSL)
Earnings in 2026 TTM: 0
According to Cambridge Nutritional Sciences plc latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cambridge Nutritional Sciences plc from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH